Mark Luz

Mark Luz has more than 15 years of strategy, finance, and analytics experience. Prior to joining Tarsus, Mark served as Vice President, Finance, and Strategic Analytics at Dermavant Sciences where he drove planning and strategy behind the commercialization of VTAMA. Prior to Dermavant, Mark worked at Avanir Pharmaceuticals where he was Senior Director of Analytics and Insights, driving analytics leadership and data-driven decisions across the organization. Previously, he held finance and payer leadership roles at UnitedHealthcare/OptumRx and a series of financial planning and strategy leadership roles in the financial services industry. Mark has a bachelor’s degree in finance from Arizona State University and an MBA from the University of Southern California.